These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 21778455)
1. Will CT take second billing to MR imaging for the diagnosis of hypervascular hepatocellular carcinomas hereafter? Kanematsu M Radiology; 2011 Aug; 260(2):607; author reply 607-8. PubMed ID: 21778455 [No Abstract] [Full Text] [Related]
2. Multidetector row CT and MR imaging in diagnosing hepatocellular carcinoma. Murakami T; Hori M; Kim T; Kawata S; Abe H; Nakamura H Intervirology; 2004; 47(3-5):209-26. PubMed ID: 15383731 [TBL] [Abstract][Full Text] [Related]
3. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092 [TBL] [Abstract][Full Text] [Related]
4. Detectability of hypervascular hepatocellular carcinoma by arterial phase images of MR and spiral CT. Murakami T; Kim T; Oi H; Nakamura H; Igarashi H; Matsushita M; Okamura J; Kozuka T Acta Radiol; 1995 Jul; 36(4):372-6. PubMed ID: 7619614 [TBL] [Abstract][Full Text] [Related]
5. Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions. Murakami T; Imai Y; Okada M; Hyodo T; Lee WJ; Kim MJ; Kim T; Choi BI Oncology; 2011; 81 Suppl 1():86-99. PubMed ID: 22212941 [TBL] [Abstract][Full Text] [Related]
6. Fast 3D dynamic MR imaging of the liver with MR SmartPrep: comparison with helical CT in detecting hypervascular hepatocellular carcinoma. Tomemori T; Yamakado K; Nakatsuka A; Sakuma H; Matsumura K; Takeda K Clin Imaging; 2001; 25(5):355-61. PubMed ID: 11682296 [TBL] [Abstract][Full Text] [Related]
7. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging. Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015 [TBL] [Abstract][Full Text] [Related]
8. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330 [TBL] [Abstract][Full Text] [Related]
12. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. Sano K; Ichikawa T; Motosugi U; Sou H; Muhi AM; Matsuda M; Nakano M; Sakamoto M; Nakazawa T; Asakawa M; Fujii H; Kitamura T; Enomoto N; Araki T Radiology; 2011 Dec; 261(3):834-44. PubMed ID: 21998047 [TBL] [Abstract][Full Text] [Related]
13. Basic analysis of dynamic study in cases of hepatocellular carcinoma using inversion recovery snap shot FLASH MR imaging with Gd-DTPA. Suto Y; Kamba M; Kato T; Ohta Y Radiat Med; 1995; 13(2):89-94. PubMed ID: 7667515 [TBL] [Abstract][Full Text] [Related]
14. Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease. Motosugi U; Ichikawa T; Sano K; Sou H; Onohara K; Muhi A; Kitamura T; Amemiya F; Enomoto N; Matsuda M; Asakawa M; Fujii H; Araki T Invest Radiol; 2011 Feb; 46(2):141-5. PubMed ID: 21139506 [TBL] [Abstract][Full Text] [Related]
15. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis. Di Martino M; Marin D; Guerrisi A; Baski M; Galati F; Rossi M; Brozzetti S; Masciangelo R; Passariello R; Catalano C Radiology; 2010 Sep; 256(3):806-16. PubMed ID: 20720069 [TBL] [Abstract][Full Text] [Related]
16. Newly developed hepatocellular carcinoma (HCC) in chronic liver disease: MR imaging findings before the diagnosis of HCC. Yu JS; Cho ES; Kim KH; Chung WS; Park MS; Kim KW J Comput Assist Tomogr; 2006; 30(5):765-71. PubMed ID: 16954925 [TBL] [Abstract][Full Text] [Related]
17. Assessing patients with hepatocellular carcinoma meeting the Milan criteria: Is liver 3 tesla MR with gadoxetic acid necessary in addition to liver CT? Cha DI; Lee MW; Kim YK; Kim SH; Park HJ; Rhim H; Lim HK J Magn Reson Imaging; 2014 Apr; 39(4):842-52. PubMed ID: 24115384 [TBL] [Abstract][Full Text] [Related]
18. Detection of hepatocellular carcinoma: comparison of dynamic MR imaging with dynamic double arterial phase helical CT. Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Kumano S; Okada A; Sugiura T; Nakamura H AJR Am J Roentgenol; 2003 Feb; 180(2):455-60. PubMed ID: 12540451 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma. Kunishi Y; Numata K; Morimoto M; Okada M; Kaneko T; Maeda S; Tanaka K AJR Am J Roentgenol; 2012 Jan; 198(1):106-14. PubMed ID: 22194485 [TBL] [Abstract][Full Text] [Related]
20. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging. Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]